Monitoring blood glucose in pregnant women receiving betamethasone for fetal lung development
Official title: Blood Glucose Levels in Pregnant Non-diabetic Women During Treatment With Betamethasone for Fetal Lung Maturation
Run by University of Aarhus · NCT06794307 · Data updated 2026-11-12
This study looks at how the medication betamethasone affects blood sugar levels in pregnant women who don't have diabetes but are at risk of preterm birth.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 25 (estimated) |
| Sponsor | University of Aarhus Academic / other |
| Locations | 1 site (Aarhus, Central Region Denmark) |
| Status | Recruiting |
| Started | November 20, 2024 |
| Main results expected | October 30, 2025 |
| Study ends | January 2026 |
| Registry record updated | January 27, 2025 |
| Trial ID | NCT06794307 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women between 24 and 34 weeks of gestation who are experiencing symptoms of threatened preterm birth and are planned to receive betamethasone.
✕Probably not a fit
Patients with diabetes or those on medications affecting glucose metabolism will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the changes in maternal blood glucose levels in non-diabetic pregnant women receiving betamethasone for fetal lung maturation during threatened preterm birth. Participants will be monitored using continuous glucose monitoring (CGM) to assess glycemic responses over a period of six days. Blood samples will also be collected to measure various metabolic markers, providing a comprehensive understanding of how betamethasone affects glucose homeostasis in this population. The study seeks to fill the knowledge gap regarding the effects of corticosteroids on non-diabetic pregnant women, which has been less explored compared to diabetic counterparts.
Why it matters
Potential benefit: If successful, this study could lead to improved management of blood glucose levels in pregnant women receiving betamethasone, potentially enhancing neonatal outcomes.
How similar studies have gone: While studies have shown the effects of betamethasone in diabetic pregnant women, this specific investigation in non-diabetic women is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant in gestational week 24+0 - 34+0 admitted with symptoms of threatened preterm birth: * Premature contractions and shortening of the cervix, or * Preterm premature rupture of membranes. * Treatment with betamethasone for fetal lung maturation is planned, or started (maximum 4 hours before inclusion) * Age over 18 years * Read and understand Danish Exclusion Criteria: * Multiple pregnancy * Diabetes * Pre-existing maternal use of medications that affect glucose metabolism
Where it's running
-
Aarhus University Hospital
Aarhus, Central Region Denmark, Denmark Recruiting
Study contacts
- Study coordinator: Victoria Bøttker
- Email: victoria.boettker@gmail.com
- Phone: +45 21253835
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Maltodextrin vs Sugar Water for Pre-Surgery Carbohydrate Loading in Older Adults
This study tests whether a maltodextrin drink before surgery leaves less fluid in the stomach than sugar water for adults 60 and older undergoing leg surgery with spinal or epidural anesthesia.
-
Managing pasireotide-related high blood sugar in acromegaly with a ketogenic diet
This study tests whether a very-low carbohydrate ketogenic diet can help lower HbA1c and fasting glucose in adults with acromegaly who develop high blood sugar while taking pasireotide.
-
Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation
This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.
-
Cervical stiffness test to help predict preterm birth in at-risk pregnant women
A simple cervical stiffness test using the Pregnolia device is being studied to see if it can better identify women with threatened preterm labor who are likely to give birth soon.
-
Risk-stratified management of inavolisib-induced hyperglycemia in breast cancer patients
This observational study tests whether using a pre-treatment risk-stratified plan to manage high blood sugar from inavolisib helps patients stay on therapy.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.